American Brivision (ABVC) SEC Filing 10-Q Quarterly report for the period ending Saturday, June 30, 2018

American Brivision

CIK: 1173313 Ticker: ABVC
Document and Entity Information - shares
6 Months Ended
Jun. 30, 2018
Aug. 17, 2018
Document and Entity Information [Abstract]  
Entity Registrant NameAmerican BriVision (Holding) Corp 
Entity Central Index Key0001173313 
Trading SymbolABVC 
Amendment Flagfalse 
Current Fiscal Year End Date--12-31 
Document Type10-Q 
Document Period End DateJun. 30, 2018 
Document Fiscal Year Focus2018 
Document Fiscal Period FocusQ2 
Entity Filer CategorySmaller Reporting Company 
Entity Common Stock, Shares Outstanding 213,926,475

View differences made from one quarter to another to evaluate American Brivision's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by American Brivision.


Assess how American Brivision's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

American Brivision's Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

American Brivision provided additional information to their SEC Filing as exhibits

Ticker: ABVC
CIK: 1173313
Form Type: 10-Q Quarterly Report
Accession Number: 0001213900-18-011469
Submitted to the SEC: Mon Aug 20 2018 5:28:02 PM EST
Accepted by the SEC: Mon Aug 20 2018
Period: Saturday, June 30, 2018
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: